IRL EXTEIN: Open Payments
NPI 1801962675 · DELRAY BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$801 in 28 payments from 8 companies in 2025. Trend: 2023 $477 · 2024 $715 · 2025 $801
Food & beverage: $801
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $225 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $143 |
| E.R. Squibb & Sons, L.L.C. | 1 | $124 |
| Otsuka America Pharmaceutical, Inc. | 6 | $115 |
| Alkermes, Inc. | 3 | $68 |
| Lundbeck LLC | 2 | $48 |
| Teva Pharmaceuticals USA, Inc. | 2 | $39 |
| Almatica Pharma LLC | 2 | $38 |
Products named: CAPLYTA, REXULTI, TRINTELLIX, COBENFY, LYBALVI, AUSTEDO XR, LOREEV XR.
Industry payments across FL — which companies pay providers there.
